Lexeo Therapeutics (LXEO) EPS (Diluted) (2022 - 2026)

Lexeo Therapeutics (LXEO) EPS (Diluted) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 0.00
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 0.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 0.15
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 4.02
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 6.75
7 Belite Bio 61.40 Bn 61.40 Bn - 0.00
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 5.52
9 Revolution Medicines 37.37 Bn 37.37 Bn - -2.29
10 Lexeo Therapeutics 379.94 Mn 379.94 Mn - -0.25

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.25
Dec 31, 2025 -0.40
Sep 30, 2025 -0.33
Jun 30, 2025 -0.60
Mar 31, 2025 -0.99
Dec 31, 2024 -0.82
Sep 30, 2024 -0.89
Jun 30, 2024 -0.64
Mar 31, 2024 -0.77
Dec 31, 2023 -2.65
Sep 30, 2023 -12.36
Jun 30, 2023 -8.30
Mar 31, 2023 -11.58
Dec 31, 2022 -8.94
Sep 30, 2022 -10.38